Superbranche
A magnetic technology platform enabling in vivo tracking of innovative therapeutic drugs, along with a theranostic approach in oncology.
About us
Superbranche
Born from a joint research unit between CNRS and the University of Strasbourg — in partnership with several hospitals — Superbranche is:
10 years of research
5 patents
4 proofs of preclinical concepts
Innovation
Why our nanoparticles are unique:
Non-ionizing magnetic imaging (MRI) and quantitative (Magnetic Particle Imaging or MPI): precise atomic and anatomical images for tracking SUPERSPIOs, as well as quantitative by MPI
Therapeutic capacity: focused magnetic hyperthermia (FMH) activation to destroy tumor cells
Compatibility with cell therapies: in vivo monitoring by magnetic imaging of innovative therapy drugs, particularly those based on stem cells or extracellular vesicles
SUPERBRANCHE's competitive advantage stems from our specific synthesis processes and know-how, which are at the heart of our innovations.
Production
Superbranche is proud to announce the construction of its GMP-compliant pilot manufacturing unit in Sélestat! This manufacturing unit will be capable of producing between 1 and 4 kg of nanoparticles per year.
Our collaborations
In a spirit of open innovation, Superbranche develops partnerships with research institutes and industrial players internationally. Our SUPERSPIO20s are currently being tested in various application contexts, thus strengthening the scientific and technological validation of our platform.
We are particularly open to collaborations in the following areas:
Advanced Cellular Tracking (stem cells, pluripotent cells or extracellular vesicles) by MRI/MPI imaging
Development of integrated solutions in biotech for diagnostics and targeted therapy
Validation of in vivo outcome innovative therapy drugs at the R&D stage, and soon in the early clinical phases
Our commitments
Superbranche is committed to a sustainable future!
Through its actions and projects, Superbranche actively supports 9 of the 17 Sustainable Development Goals defined by the UN.
From equal opportunities to responsible innovation and the preservation of our planet, we believe it is possible to combine positive impact and entrepreneurial boldness.
Act locally, think globally. This is our connection to the future.
Latest News
In Sélestat, Superbranche will open a pilot plant for nanomaterials
Superbranche will open a pilot plant in Sélestat in September 2025 dedicated to the production of medical nanomaterials.
Ranking: the top 10 largest fundraising rounds in French Tech in February 2025
Superbranche is among the 10 largest fundraising rounds in French Tech in February 2025 with funding of 13 million euros.
Cancer treatment: Superbranche will industrialize its nanoparticles
Superbranche is moving to the industrial stage with its nanoparticles dedicated to cancer treatment, particularly via innovative thermal approaches.
Contact us
Would you like to know more or start a collaboration?
Do not hesitate to write to us, our team will be happy to respond to you as soon as possible.